1 kits (10 Vials)
| samuwa: | |
|---|---|
| Yawan: | |
Menene Crystagen?
Crystagen shine mai daidaita yanayin halitta na peptide na roba da farko wanda ya ƙunshi proline, glutamic acid, da aspartic acid. Babban aikinsa shi ne haɓaka martanin rigakafi na jiki da juriya na damuwa ta hanyar daidaita aikin tsarin rigakafi.
▎ Crystagen Tsarin
Source: PepDraw |
Tsarin kwayoyin halitta: C 14H 11N 3O8 Nauyin Kwayoyin Halitta: 359.34g/mol |
▎ Ovagen Binciken
Menene asalin bincike na Crystagen?
Asalin bincike na Crystagen da farko ya samo asali ne daga zurfafa bincike kan tsarin tsarin rigakafi da tsarin ilimin halitta masu alaƙa da tsufa. Tare da tsufa, ma'auni na haɗin furotin da aiki a cikin jiki yana rushewa, yana haifar da farawar cututtuka daban-daban. A matsayin ɗan gajeren sarkar peptide bio-modulator, jerin Crystagen-wanda ya ƙunshi glutamic acid (Glu), aspartic acid (Asp), da proline (Pro) - yana kunna maganganun kwayoyin halitta ta hanyar haɗawa da takamaiman rukunin DNA. Wannan yana haɓaka haɗin furotin, ta haka yana ci gaba da ayyukan ilimin lissafi. Wannan tsarin yana ba da tushe na ka'idar don jinkirta tsufa da haɓaka aikin rigakafi.
Menene tsarin aikin Crystagen?
Kunna ƙwayoyin B a cikin tsarin rigakafi
Kunna ƙwayoyin B kai tsaye: Crystagen yana kunna ƙwayoyin B a cikin tsarin rigakafi. Kwayoyin B da farko suna samar da ƙwayoyin rigakafi kuma suna shiga cikin martanin rigakafi na ban dariya. Lokacin da ƙwayoyin cuta suka mamaye jiki, ƙwayoyin B suna gane antigens kuma suna kunna ta hanyar jerin hanyoyin sigina. Daga nan sai su bambance sel na plasma waɗanda ke ɓoye takamaiman ƙwayoyin cuta don kawar da ƙwayoyin cuta. Crystagen na iya kunna ƙwayoyin B ta hanyar ɗaure ga takamaiman masu karɓa akan saman su, yana haifar da hanyoyin siginar intracellular. Wannan yana haɓaka ikon ƙwayoyin B don gane antigens da fara amsawar rigakafi [1].
Menene aikace-aikacen Crystagen?
A cikin tsarin rigakafi, Crystagen yana haɓaka aikin garkuwar jiki sosai, yana sa ya zama mai fa'ida don magance cututtuka daban-daban masu alaƙa da rigakafi. Ana iya amfani da shi don magance kumburi mai tsanani ko na kullum, ciki har da cututtuka na numfashi na numfashi (kamar pharyngitis, mashako, sinusitis, ciwon huhu, da dai sauransu), cututtuka na urinary fili (irin su cystitis, pyelonephritis), prostatitis, adnexitis. Crystagen kuma yana nuna tasiri mai kyau a cikin magance cututtuka na autoimmune da cututtuka na tsarin haɗin kai, yana ba da sababbin hanyoyin warkewa don waɗannan yanayi.
A cikin saitunan bayan aiki da gyaran gyare-gyare, ana iya amfani da Crystagen a lokacin hanyoyin tiyata daban-daban kafin da kuma bayan aiki don taimakawa marasa lafiya don dawo da ƙarfin jiki da aikin rigakafi. Ga marasa lafiya da ke murmurewa daga bugun zuciya ko bugun jini, Crystagen yana inganta farfadowar jiki kuma yana rage abubuwan da ke faruwa. Aikace-aikacen sa a cikin tsofaffi marasa lafiya da mutanen da ba su da rigakafi kuma suna samun kulawa sosai. Yana taimakawa wajen kula da aikin rigakafi a cikin tsofaffi kuma yana inganta raguwar rigakafi na shekaru. Ga marasa lafiya da abubuwan da ba su da kyau suka shafa kamar cututtuka, radiation, chemotherapy, damuwa na tunanin mutum, abubuwan muhalli, yanayin yanayi, cututtuka na endemic, da radiation ionizing, Crystagen yana haifar da sakamako mai kyau na tsari, yana haɓaka juriya na cututtuka na jiki.
Crystagen kuma yana nuna yuwuwar rigakafin ƙwayar cuta. Ta hanyar daidaita aikin tsarin rigakafi, yana iya taimakawa rage haɗarin ci gaban ƙari. Bugu da ƙari, ana iya amfani da Crystagen a cikin maganin guba na yau da kullum, yana taimakawa wajen dawo da marasa lafiya masu guba.
Kammalawa
A matsayin mai daidaita yanayin halitta na peptide na roba, Crystagen yana nuna tasirin immunomodulatory, haɓaka aikin rigakafi da inganta yanayin ƙarancin rigakafi da ke haifar da dalilai daban-daban. Yana nuna inganci wajen magance kumburi mai tsanani ko na yau da kullun, cututtukan hoto ko bidiyo mai zagaya yanar gizo da sauri, farfadowa bayan tiyata, da raguwar rigakafi masu alaƙa da shekaru. Crystagen kuma yana yin tasiri mai kyau a cikin rigakafin ƙwayar cuta da maganin guba na yau da kullun.
Game da Marubuci
Abubuwan da aka ambata a sama duk bincike ne, gyara su kuma Cocer Peptides ne suka haɗa su.
Mawallafin Jaridar Kimiyya
Chervyakova NA wani mai bincike ne a Cibiyar Nazarin Halittu da Gerontology ta Saint-Petersburg, Rasha, yana mai da hankali kan nau'ikan kwayoyin halitta na immunomodulation da canje-canje masu alaƙa da shekaru a cikin aikin rigakafi. Chervyakova NA an jera shi a cikin ambaton ambaton [1].
▎ Abubuwan da suka dace
[1] Shervyakova NA, Linkova NS, Chalisova NI, Koncevaya EA, Trofimova SV, Khavinson VK. [Hanyoyin kwayoyin halitta na aikin rigakafi na peptides a cikin maɗaura yayin tsarin tsufa]. Ci gaba a Gerontology 2014; 27 (1): 224-228.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgicmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=28976144&query_hl=1.
DUKKANIN LABARI DA BAYANIN KYAUTATAWA DA AKE BAYAR A WANNAN SHAFIN KAWAI DOMIN WATSA BAYANI NE DA MANUFOFIN ILIMI.
Kayayyakin da aka bayar akan wannan gidan yanar gizon an yi niyya ne kawai don binciken in vitro. Binciken in vitro (Latin: *a cikin gilashi*, ma'ana a cikin gilashin gilashi) ana gudanar da shi a wajen jikin mutum. Waɗannan samfuran ba magunguna ba ne, Hukumar Abinci da Magunguna ta Amurka (FDA) ba ta amince da su ba, kuma dole ne a yi amfani da su don hanawa, magani, ko warkar da duk wani yanayi na likita, cuta, ko cuta. Doka ta haramta shigar da waɗannan samfuran cikin jikin mutum ko dabba ta kowace hanya.